{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:07:00Z","timestamp":1782320820123,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013759","name":"Commonwealth Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA244993"],"award-info":[{"award-number":["R01 CA244993"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA280194"],"award-info":[{"award-number":["R01 CA280194"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA259599"],"award-info":[{"award-number":["R01 CA259599"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016350","name":"Virginia Commonwealth University Massey Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phrs.2026.108164","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:38:20Z","timestamp":1774078700000},"page":"108164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MDA-9\/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis"],"prefix":"10.1016","volume":"227","author":[{"given":"Santanu","family":"Maji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanabhan","family":"Mannangatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkal","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion Q.","family":"LoPresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitai D.","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Pangeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Webster L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swadesh K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2026.108164_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051518","article-title":"Bone metastases and health in prostate cancer: from pathophysiology to clinical implications","volume":"15","author":"Baldessari","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108164_bib2","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.3286","article-title":"Pain management in metastatic bone disease: a literature review","author":"Ahmad","year":"2018","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.phrs.2026.108164_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12051075","article-title":"Intersecting paths: unraveling the complex journey of cancer to bone metastasis","volume":"12","author":"Arakil","year":"2024","journal-title":"Biomedicines"},{"issue":"45","key":"10.1016\/j.phrs.2026.108164_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307094120","article-title":"MDA-9\/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis","volume":"120","author":"Maji","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108164_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2024.04.007","article-title":"Molecular landscape of prostate cancer bone metastasis","volume":"161","author":"Maji","year":"2024","journal-title":"Adv. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108164_bib6","first-page":"317","article-title":"Characterization of a novel melanoma differentiation-associated gene, mda-9, that is down-regulated during terminal cell differentiation","volume":"4","author":"Lin","year":"1996","journal-title":"Mol. Cell. Differ."},{"issue":"2","key":"10.1016\/j.phrs.2026.108164_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(97)00562-3","article-title":"Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene","volume":"207","author":"Lin","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2026.108164_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104695","article-title":"MDA-9\/Syntenin (SDCBP): novel gene and therapeutic target for cancer metastasis","volume":"155","author":"Das","year":"2020","journal-title":"Pharm. Res"},{"issue":"11","key":"10.1016\/j.phrs.2026.108164_bib9","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1158\/0008-5472.CAN-17-2992","article-title":"The MDA-9\/Syntenin\/IGF1R\/STAT3 axis directs prostate cancer invasion","volume":"78","author":"Das","year":"2018","journal-title":"Cancer Res."},{"issue":"41","key":"10.1016\/j.phrs.2026.108164_bib10","doi-asserted-by":"crossref","first-page":"15914","DOI":"10.1073\/pnas.0808171105","article-title":"mda-9\/Syntenin promotes metastasis in human melanoma cells by activating c-Src","volume":"105","author":"Boukerche","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2026.108164_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.1616100114","article-title":"Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9\/Syntenin","volume":"114","author":"Kegelman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.phrs.2026.108164_bib12","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1158\/0008-5472.CAN-05-1614","article-title":"mda-9\/Syntenin: a positive regulator of melanoma metastasis","volume":"65","author":"Boukerche","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108164_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2025.2472042","article-title":"MDA-9\/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding","volume":"29","author":"Das","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"issue":"30","key":"10.1016\/j.phrs.2026.108164_bib14","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10040","article-title":"Knockout of MDA-9\/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis","volume":"7","author":"Das","year":"2016","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.phrs.2026.108164_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103180118","article-title":"Pharmacological inhibition of MDA-9\/Syntenin blocks breast cancer metastasis through suppression of IL-1beta","volume":"118","author":"Pradhan","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108164_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.imbio.2014.12.003","article-title":"Increased production of intestinal immunoglobulins in Syntenin-1-deficient mice","volume":"220","author":"Tamura","year":"2015","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.phrs.2026.108164_bib17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1535-7163.MCT-18-1019","article-title":"Suppression of prostate cancer pathogenesis using an MDA-9\/Syntenin (SDCBP) PDZ1 small molecule inhibitor","volume":"18","author":"Das","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"41","key":"10.1016\/j.phrs.2026.108164_bib18","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1038\/s41388-019-0920-5","article-title":"Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9\/Syntenin","volume":"38","author":"Bhoopathi","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Chemin.."},{"key":"10.1016\/j.phrs.2026.108164_bib20","unstructured":"Schrodinger Release 2024-4: Glide. New York, NY: Schrodinger, LLC; 2024."},{"issue":"20","key":"10.1016\/j.phrs.2026.108164_bib21","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1158\/0008-5472.CAN-14-0018","article-title":"AEG-1 promoter-mediated imaging of prostate cancer","volume":"74","author":"Bhatnagar","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108164_bib22","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1535-7163.MCT-12-0164","article-title":"situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer","volume":"11","author":"Guo","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"6141","key":"10.1016\/j.phrs.2026.108164_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.phrs.2026.108164_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1158\/1535-7163.MCT-22-0653","article-title":"Dual Targeting of the PDZ1 and PDZ2 domains of MDA-9\/syntenin inhibits melanoma metastasis","volume":"22","author":"Pradhan","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"131","key":"10.1016\/j.phrs.2026.108164_bib25","doi-asserted-by":"crossref","DOI":"10.3791\/56750","article-title":"Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice","author":"Maridas","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"9","key":"10.1016\/j.phrs.2026.108164_bib26","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1535-7163.MCT-17-1002","article-title":"Recombinant MDA-7\/IL24 suppresses prostate cancer bone metastasis through downregulation of the Akt\/Mcl-1 pathway","volume":"17","author":"Pradhan","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010053","article-title":"MDA-9\/Syntenin (SDCBP) is a critical regulator of chemoresistance, survival and stemness in prostate cancer stem cells","volume":"12","author":"Talukdar","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.phrs.2026.108164_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043431","article-title":"Inhibitors against Two PDZ Domains of MDA-9 suppressed migration of breast cancer cells","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2026.108164_bib29","first-page":"1210","article-title":"Direct-reversible binding of small molecules to G protein betagamma subunits. Biochim Biophys Acta","volume":"1814","author":"Seneviratne","year":"2011"},{"issue":"3","key":"10.1016\/j.phrs.2026.108164_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1476-5381.2010.00936.x","article-title":"Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action","volume":"161","author":"Vauquelin","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2026.108164_bib31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.18632\/oncotarget.28281","article-title":"Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer","volume":"13","author":"Moench","year":"2022","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.phrs.2026.108164_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081947","article-title":"Platelet-derived PDGFB promotes recruitment of cancer-associated fibroblasts, deposition of extracellular matrix and tgfbeta signaling in the tumor microenvironment","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.phrs.2026.108164_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cbf.3120","article-title":"Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape","volume":"33","author":"Farooqi","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.phrs.2026.108164_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1478-811X-11-97","article-title":"Targeting the PDGF signaling pathway in tumor treatment","volume":"11","author":"Heldin","year":"2013","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.phrs.2026.108164_bib35","first-page":"572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2026.108164_bib36","article-title":"PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRalpha and derepressing BMP-Smad1\/5\/8 signaling","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.phrs.2026.108164_bib37","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1359\/jbmr.080409","article-title":"PDGF receptor beta is a potent regulator of mesenchymal stromal cell function","volume":"23","author":"Tokunaga","year":"2008","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.phrs.2026.108164_bib38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3389\/fphys.2019.01467","article-title":"Yes-associated protein 1 plays major roles in pancreatic stellate cell activation and fibroinflammatory responses","volume":"10","author":"Hu","year":"2019","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/or.2020.7859","article-title":"Platelet\u2011derived growth factor\u2011BB mediates pancreatic cancer malignancy via regulation of the Hippo\/Yes\u2011associated protein signaling pathway","volume":"45","author":"Li","year":"2021","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2026.108164_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1593\/neo.07976","article-title":"CXCL5 promotes prostate cancer progression","volume":"10","author":"Begley","year":"2008","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI92466","article-title":"Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone","volume":"128","author":"Roca","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2-3","key":"10.1016\/j.phrs.2026.108164_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cac2.12010","article-title":"CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target","volume":"40","author":"Zhang","year":"2020","journal-title":"Cancer Commun"},{"issue":"11","key":"10.1016\/j.phrs.2026.108164_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113093","article-title":"Tumor Lymphatic Interactions induce CXCR2-CXCL5 axis and alter cellular metabolism and lymphangiogenic pathways to promote cholangiocarcinoma","volume":"10","author":"Roy","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108164_bib44","unstructured":"T.H. Kim, S. Shin, J.B. Bulitta, Y.S. Youn, S.D. Yoo, B.S. ShinDevelopment of a physiologically relevant population pharmacokinetic in vitro-in vivo correlation approach for designing extended-release oral dosage formulation 1 142017, 41536510.1021\/acs.molpharmaceut.6b00677."},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2008.03.021","article-title":"Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs","volume":"129","author":"Dahan","year":"2008","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.phrs.2026.108164_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-016-2094-0","article-title":"Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial","volume":"128","author":"Khasraw","year":"2016","journal-title":"J. Neurooncol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108164_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40787","article-title":"Mortality risk for docetaxel-treated, high-grade prostate cancer with low psa levels: a meta-analysis","volume":"6","author":"Mahal","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.phrs.2026.108164_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1758834017692779","article-title":"Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting","volume":"9","author":"Puente","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108164_bib49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41416-020-0965-9","article-title":"Syntenin-1 promotes colorectal cancer stem cell expansion and chemoresistance by regulating prostaglandin E2 receptor","volume":"123","author":"Iwamoto","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.phrs.2026.108164_bib50","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3390\/cancers13194952","article-title":"SDCBP Modulates Stemness and chemoresistance in head and neck squamous cell carcinoma through src activation","volume":"13","author":"Cristina Mir","year":"2021","journal-title":"Cancers"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:35:04Z","timestamp":1778020504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"alternative-id":["S1043661826000794"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108164","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDA-9\/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108164"}}